Dr. Andrea Leigh Haller, MD

Dr. Haller practices at Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana.

Dr. Haller's NPI, 1407853146, was assigned on July 7, 2005. Dr. Haller graduated from University of California, San Francisco School of Medicine in 1997. Dr. Haller holds Indiana license 01053486A.

Dr. Haller's primary practice is Ascension St Vincent Hospital- Indianapolis, at 2001 W 86th St, Indianapolis, IN 46260 in Marion County. The practice phone is (317) 338-2172.

Dr. Haller's primary practice is Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana. Dr. Haller is also affiliated with Parkview Regional Medical Center. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Haller to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haller practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Haller's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Haller is licensed in Indiana.

CMS data shows 762 Medicare services from Dr. Haller across 15 procedure codes in 2024, for 329 Medicare patients. Medicare paid $54,367 for them.

CMS counts 329 Medicare patients who saw Dr. Haller in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Haller's median patient age at 66, with 59% women.

In 2024, Dr. Haller wrote 2,881 Medicare Part D claims for 448 patients. 86% of them were for generic drugs. CMS names the drug for 2,634 of them, across 53 drugs with 11 or more claims each, at $787,875 in total drug cost. In 2023, CMS named 2,111 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 50 out of 100 for Dr. Haller for performance year 2024, reported as part of a group. Dr. Haller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haller as offering telehealth. CMS counts 12 procedures of skin biopsy by Dr. Haller, more than 60% of the clinicians it reports for that procedure.

Dmand AI links Dr. Haller to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Migraine Disorders and Headache Disorders, Primary. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Haller that name 2 trials.

CMS Open Payments shows 786 general payments to Dr. Haller from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Abbvie Inc. paid the most, $115,466. It also lists 5 research payments totaling $17,848 from 2020 to 2022, naming 2 clinical trials.

Dr. Haller graduated from University of California, San Francisco School of Medicine in 1997.